Content
01/12/2024
San Francisco, CA USA
Rune Labs
completed $12 million Growth Round funding. Investors include
Nexus NeuroTech Ventures (lead), Eclipse, DigiTx Partners, Moment Ventures, TruVenturo GmbH.
About
The last decade has seen amazing progress in neuroscience, enabling researchers to envision a new generation of brain machine interfaces. These systems will be used to treat chronic diseases like Parkinson's, epilepsy, and Alzheimer's. They will restore mobility to the paralyzed and speed recovery from a stroke. They may even allow us to control our mood and enhance our cognition. Rune Labs wants to build the software at the heart of these systems, and help accelerate the next wave of neuromodulation applications.
Startup
Sector:
Biotech
MedTech
Healthcare
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
